98 related articles for article (PubMed ID: 21419539)
1. Getting evidence into policy: The need for deliberative strategies?
Flitcroft K; Gillespie J; Salkeld G; Carter S; Trevena L
Soc Sci Med; 2011 Apr; 72(7):1039-46. PubMed ID: 21419539
[TBL] [Abstract][Full Text] [Related]
2. How do drug policy makers access research evidence?
Ritter A
Int J Drug Policy; 2009 Jan; 20(1):70-5. PubMed ID: 18226519
[TBL] [Abstract][Full Text] [Related]
3. Capitalising upon political opportunities to reform drug policy: a case study into the development of the Australian "Tough on Drugs-Illicit Drug Diversion Initiative".
Hughes CE
Int J Drug Policy; 2009 Sep; 20(5):431-7. PubMed ID: 19162458
[TBL] [Abstract][Full Text] [Related]
4. Using social network analysis to examine the decision-making process on new vaccine introduction in Nigeria.
Wonodi CB; Privor-Dumm L; Aina M; Pate AM; Reis R; Gadhoke P; Levine OS
Health Policy Plan; 2012 May; 27 Suppl 2():ii27-38. PubMed ID: 22513730
[TBL] [Abstract][Full Text] [Related]
5. Evidence-based policy or policy-based evidence? The role of evidence in the development and implementation of the Illicit Drug Diversion Initiative.
Hughes CE
Drug Alcohol Rev; 2007 Jul; 26(4):363-8. PubMed ID: 17564871
[TBL] [Abstract][Full Text] [Related]
6. Start-stop funding, its causes and consequences: a case study of the delivery exemptions policy in Ghana.
Witter S; Adjei S
Int J Health Plann Manage; 2007; 22(2):133-43. PubMed ID: 17623355
[TBL] [Abstract][Full Text] [Related]
7. Managing the intractable: communicative structures for management of hexachlorobenzene and other scheduled wastes.
Rae I; Brown P
J Environ Manage; 2009 Apr; 90(4):1583-92. PubMed ID: 18804322
[TBL] [Abstract][Full Text] [Related]
8. A policy case study of blood in Australia.
Graves N; Clare G; Haines M; Bird R
Soc Sci Med; 2010 Nov; 71(9):1677-82. PubMed ID: 20843593
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based policy-making: the implications of globally-applicable research for context-specific problem-solving in developing countries.
Behague D; Tawiah C; Rosato M; Some T; Morrison J
Soc Sci Med; 2009 Nov; 69(10):1539-46. PubMed ID: 19781839
[TBL] [Abstract][Full Text] [Related]
10. The impact of context on evidence utilization: a framework for expert groups developing health policy recommendations.
Dobrow MJ; Goel V; Lemieux-Charles L; Black NA
Soc Sci Med; 2006 Oct; 63(7):1811-24. PubMed ID: 16764980
[TBL] [Abstract][Full Text] [Related]
11. Decision-makers and the usefulness of research evidence in policy implementation--a case study from Lao PDR.
Tomson G; Paphassarang C; Jönsson K; Houamboun K; Akkhavong K; Wahlström R
Soc Sci Med; 2005 Sep; 61(6):1291-9. PubMed ID: 15970238
[TBL] [Abstract][Full Text] [Related]
12. Risk management frameworks for human health and environmental risks.
Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
[TBL] [Abstract][Full Text] [Related]
13. Research use in children's mental health policy in Canada: maintaining vigilance amid ambiguity.
Waddell C; Lavis JN; Abelson J; Lomas J; Shepherd CA; Bird-Gayson T; Giacomini M; Dan Offord DR
Soc Sci Med; 2005 Oct; 61(8):1649-57. PubMed ID: 16029772
[TBL] [Abstract][Full Text] [Related]
14. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
15. From "our world" to the "real world": Exploring the views and behaviour of policy-influential Australian public health researchers.
Haynes AS; Derrick GE; Chapman S; Redman S; Hall WD; Gillespie J; Sturk H
Soc Sci Med; 2011 Apr; 72(7):1047-55. PubMed ID: 21414704
[TBL] [Abstract][Full Text] [Related]
16. Intergovernmental health policy decisions in Brazil: cooperation strategies for political mediation.
Miranda AS
Health Policy Plan; 2007 May; 22(3):186-92. PubMed ID: 17485420
[TBL] [Abstract][Full Text] [Related]
17. The Australian funding debate on quadrivalent HPV vaccine: a case study for the national pharmaceutical policy.
Roughead EE; Gilbert AL; Vitry AI
Health Policy; 2008 Dec; 88(2-3):250-7. PubMed ID: 18468714
[TBL] [Abstract][Full Text] [Related]
18. Knowledge-based changes to health systems: the Thai experience in policy development.
Tangcharoensathien V; Wibulpholprasert S; Nitayaramphong S
Bull World Health Organ; 2004 Oct; 82(10):750-6. PubMed ID: 15643796
[TBL] [Abstract][Full Text] [Related]
19. European micronutrient recommendations aligned: a general framework developed by EURRECA.
Dhonukshe-Rutten RA; Timotijevic L; Cavelaars AE; Raats MM; de Wit LS; Doets EL; Tabacchi G; Roman B; Ngo-de la Cruz J; Gurinovic M; de Groot LC; van 't Veer P
Eur J Clin Nutr; 2010 Jun; 64 Suppl 2():S2-10. PubMed ID: 20517317
[TBL] [Abstract][Full Text] [Related]
20. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
